据美国芝加哥大学肝病研究所负责人Baker统计,美国因肝病死亡者居总死亡数的第七位,其中,酒精性肝炎与酒精性肝硬化要占半数左右。Baker博士采用胰岛素和胰高血糖素静脉滴注疗法,可使原来只用单一标准给药方案的急性酒精性肝炎和肝硬化病人的死亡率下降一半。目前,这种“肝细胞再生疗法”尚处于试用阶段。该研究所对56名酒精性肝病的男女患者,以胰岛素—胰高血糖素治疗与采用 According to Baker, head of the Institute of Liver Diseases at the University of Chicago, the seventh-largest death toll from liver disease in the United States accounts for about half of alcoholic hepatitis and alcoholic cirrhosis. Using insulin and glucagon intravenous drip therapy, Dr. Baker halved the mortality of patients with acute alcoholic hepatitis and cirrhosis who used only a single standard regimen. At present, this “hepatocyte regeneration therapy ” is still in the trial phase. The Institute of 56 patients with alcoholic liver disease in patients with male and female insulin-glucagon treatment and use